Representatives of Brussels-based offices leading the work of Health Working Group.
ERRIN’s Health Working Group (WG) supports members with early intelligence and regular updates about EU-level health policy-related issues, regulations, EU programmes and their funding opportunities. Creating opportunities for interregional cooperation in the Health area is one of the WG’s main objectives. The WG is also a vehicle for networking, profile raising and promoting good practices and projects among health stakeholders in the ERRIN regions.
The topic of widening gathers high attention in the discussions around the next European Framework Programme for R&I, raising questions with the potential to influence not only the Widening sub-
The Health Working Group meeting will update colleagues on the European Commission’s initiatives linked to staff and skills shortages and training and up-skilling of the health workforce, exploring
ERRIN has been closely involved in the design and implementation of the EU Missions since their inception. Missions remain one of the network's priorities and were one of the four main areas of focus
The 22nd International Conference on Integrated Care will take place in Odeon in Odense and online from 23 - 25 May.
During its final ERA CoBioTech Hub Meeting, which will take place as a virtual conference on 19 May 2022, ERA CoBioTech gathers the diverse actors of the new European Partnerships and in the fields of biotechnology, bioeconomy, life sciences and other innovative technologies.
The European Commission has announced dedicated Info-Days for the EU Missions to be held virtually on 17 and 18 May 2022. The event will provide prospective applicants with specific information on the new Missions’ Work Programme calls, funding opportunities and timelines.
This year's edition of the Week of Innovative Regions in Europe (WIRE) will take place on 11-13 May 2022 under the theme “Towards a leading Europe in breakthrough innovation: unleashing the potential of regions”. The event will be hosted by Université Paris-Saclay, France, under the French Presidency of the Council of the European Union.
The Global Health EDCTP3 Joint Undertaking (GH EDCTP3 JU) will host its launch event on 10 May 2022.
On 25-26 April 2022, SAPHIRe project will hold its final conference entitled “Personalised Medicine in European Regions - A Roadmap to the Future of Medicine”. The event will provide insight and inspiration into how regions contribute to the development and implementation of personalised medicine.
The ERRIN Year in review 2022 is out! Read the report to see the numerous activities ERRIN and its members have been involved in throughout the year.
Please find attached ERRIN and the network of European Regional and Local Health Authorities (EUREGHA)'s joint statement on the Horizon Europe Mission on Cancer.
Further to the Health WG meeting on the Cancer Mission, EUREGHA and ERRIN have decided to address the Cancer Mission Board with a statement to emphasise the role of regions in this mission.
The Eu Cancer Mission project ONCODIR is organising a survey to consolidate its research work on the primary prevention of colorectal cancer. The survey is intended for citizens, clinicians and policymakers, and will expire on 31 July. It is a multiple-choice questionary and will take between 5-10 minutes to complete.
ERRIN is pleased to launch a series of input papers on the 10th Framework Programme, with this paper focusing on EU Missions. ERRIN has been closely involved in the design and implementation of the EU Missions since their inception, making them a priority for the network. This input paper on the role of EU Missions in FP10 has been created with contributions from ERRIN members and their ecosystems.
The REINFORCING project has opened a call to support organisations and territories that actively contribute to the EU Missions by engaging relevant stakeholders, including citizens, in the R&I process and/or policies connected to one of the Missions. Successful proposals will receive up to 60,000 euros to implement a 12-month project. The deadline for submitting proposals is 26 September 2024.
ERRIN is pleased to share a two-pager for the incoming European decision-makers, aiming to present the network and our value to the new MEPs, raising a voice for the importance of place-based R&I in the changing landscape. We encourage all ERRIN members to share the document with their MEPs to introduce ERRIN and the value of place-based R&I.
On 19 June, the Commission announced the 151 regions identified as Regional Innovation Valleys following the call for EoI and calls for proposals in 2023. 75 successful regions come from ERRIN members. RIVs will aim to strengthen the regional innovation ecosystems, bridge the innovation gap and improve Europe's overall innovation performance. New calls for proposals under Horizon Europe are expected in 2025.
As the work towards the next EU Framework Programme for R&I (FP10) continues, ERRIN is pleased to share its two-page input for the attention of the Expert Group on the interim evaluation of Horizon Europe. The document is a concise compilation of the reflections on FP10 done at ERRIN so far, highlighting topics of key importance. Work on a series of broader input papers is underway.
Wrocław University of Environmental and Life Sciences - UPWr is looking for a consortium or a coordinator interested in the BBI JU call.
The Farm to Fork Strategy aims for healthy and sustainable EU food system. The main priorities focus on tackling the climate change, preserving the biodiversity, protecting the environment, and enhancing access to healthy organic food.
A new call has launched, making €56 million available for medical technologies, digital tools and Artificial Intelligence (AI) that can offer solutions to the coronavirus crisis.
Help shape the call by taking part in the surveys for each of the 11 areas. Deadline 3 June 2020.
SAPHIRe will host an online interactive workshop on the topic “Exit strategies for COVID-19 lockdown, what role do regions play” and invites you to represent your region and speak about your approach to the COVID-19 exit strategy.
The Commission has increased its financial commitment to the Innovative Medicines Initiative to €72 million in order to fund eight projects focussed on coronavirus diagnostics and treatment.